Sexual harassment common in surgical training programs
By Carolyn Crist (Reuters Health) – About seven in 10 young female surgeons say they have...
Read MoreApr 16, 2019
By Carolyn Crist (Reuters Health) – About seven in 10 young female surgeons say they have...
Read MoreApr 16, 2019
(Reuters) – The number of confirmed cases of measles in the United States this year jumped...
Read MoreApr 16, 2019
(Reuters) – Gilead Sciences Inc said on Tuesday it will partner with privately held insitro...
Read MoreApr 16, 2019
BEIJING (Reuters) – China will allow large-scale pig farms and breeding farms to test for...
Read MoreApr 15, 2019
By Lisa Rapaport (Reuters Health) – Older adults who are victims of financial scams may be...
Read MoreApr 15, 2019
By Linda Carroll (Reuters Health) – The Food and Drug Administration’s new mandatory...
Read MoreApr 15, 2019
By Lisa Rapaport (Reuters Health) – Over a typical 24-hour shift, first year residents training in internal medicine spend just three hours on direct patient care and only 1.8 hours on education, a U.S. study suggests....
Read MoreApr 15, 2019
By Deena Beasley (Reuters) – Amgen Inc on Monday set the U.S. list price for its new Evenity...
Read MoreApr 15, 2019
By Lisa Rapaport (Reuters Health) – People who regularly use cannabis may need more than...
Read MoreApr 15, 2019
By Saumya Joseph (Reuters) – Contract drugmaker Catalent Inc said on Monday it would buy privately held Paragon Bioservices Inc for $1.2 billion in cash, bolstering its capabilities to make gene therapy drugs for its...
Read MoreApr 15, 2019
GENEVA (Reuters) – The number of measles cases worldwide nearly quadrupled in the first...
Read MoreApr 15, 2019
By Lawrence Hurley WASHINGTON (Reuters) – The U.S. Supreme Court on Monday cast aside...
Read MoreApr 14, 2019
(Reuters) – Drug developer Catalent Inc has agreed to buy privately held, gene-therapy focused Paragon Bioservices Inc for $1.2 billion, the Wall Street Journal reported on Sunday, citing people familiar with the matter....
Read MoreApr 13, 2019
By Gina Cherelus (Reuters) – An Indianapolis food company has voluntarily recalled fresh cut...
Read MoreApr 13, 2019
(Reuters) – The U.S. Food and Drug Administration (FDA) said on Friday it has sent letters...
Read MoreApr 12, 2019
(Reuters) – Johnson & Johnson’s drug Balversa won U.S. approval as the first...
Read MoreApr 12, 2019
(Reuters) – Clovis Oncology Inc said on Friday it was halting a mid-stage trial testing its...
Read MoreApr 12, 2019
By Lisa Rapaport (Reuters Health) – A growing number of American children are being treated in emergency rooms after swallowing foreign objects like coins, toys, and jewelry, a U.S. study suggests. Researchers examined...
Read MoreApr 12, 2019
By Lisa Rapaport (Reuters Health) – Roughly half of patients with cancer have symptoms of...
Read MoreApr 12, 2019
By Linda Carroll (Reuters Health) – Patients often assume that surgical outcomes at all...
Read More